Actions biotechnologiques — Analyse et classements par IA
Cette page a été traduite automatiquement de l'original anglais par IA ; la version anglaise fait foi. Lire la version anglaise
Réponse Rapide
Parcourez toutes les actions biotechnologiques avec une analyse basée sur l'IA, les MoonshotScores et les objectifs de prix.
Parcourez toutes les actions biotechnologiques avec une analyse basée sur l'IA, les MoonshotScores et les objectifs de prix.
Actions Similaires dans le secteur Biotechnologie
| Société | Prix | Variation | Capitalisation boursière | MoonshotScore |
|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals Inc. | $16.86 | -2.71% | $2.24B | — |
| EXEL Exelixis, Inc. | $64.53 | -1.19% | $16.2B | — |
| INCY Incyte Corporation | $113.31 | -2.07% | $23.0B | — |
| KRYS Krystal Biotech, Inc. | $312.93 | +0.46% | $9.26B | — |
| NRIX Nurix Therapeutics, Inc. | $25.25 | -0.36% | $2.76B | — |
| UTHR United Therapeutics Corporation | $587.46 | -0.01% | $25.2B | — |
| ARGX argenx SE | $869.33 | -0.50% | $54.7B | — |
| HALO Halozyme Therapeutics, Inc. | $126.80 | +0.93% | $14.4B | — |
| HRMY Harmony Biosciences Holdings, Inc. | $36.13 | +0.28% | $2.10B | — |
| VRTX Vertex Pharmaceuticals Incorporated | $517.49 | -1.23% | $131B | — |
| ETON Eton Pharmaceuticals, Inc. | $50.17 | +0.34% | $1.43B | — |
| LGND Ligand Pharmaceuticals Incorporated | $303.53 | -1.39% | $6.05B | — |
| VCYT Veracyte, Inc. | $48.20 | +0.56% | $3.87B | — |
| ADMA ADMA Biologics, Inc. | $10.99 | +2.86% | $2.46B | — |
| CRMD CorMedix Inc. | $7.85 | -3.09% | $612M | — |
| INVA Innoviva, Inc. | $20.66 | -1.90% | $1.49B | — |
| LQDA Liquidia Corporation | $43.74 | +2.56% | $3.92B | — |
| REGN Regeneron Pharmaceuticals, Inc. | $807.67 | +0.33% | $83.2B | — |
| NBIX Neurocrine Biosciences, Inc. | $145.87 | +2.22% | $14.8B | — |
| RIGL Rigel Pharmaceuticals, Inc. | $49.55 | +2.96% | $926M | — |
| TECH Bio-Techne Corporation | $72.55 | -0.10% | $11.4B | — |
| VCEL Vericel Corporation | $42.53 | -1.02% | $2.18B | — |
| ARQT Arcutis Biotherapeutics, Inc. | $31.20 | -3.11% | $3.92B | — |
| ALNY Alnylam Pharmaceuticals, Inc. | $231.49 | +3.33% | $31.0B | — |
| CAI Caris Life Sciences, Inc. | $32.23 | +0.70% | $9.11B | — |
| NVO Novo Nordisk A/S | $39.13 | +0.20% | $173B | — |
| ZVRA Zevra Therapeutics, Inc. | $9.53 | -2.85% | $566M | — |
| ASND Ascendis Pharma A/S | $243.37 | +0.16% | $15.2B | — |
| MDXG MiMedx Group, Inc. | $3.91 | -0.51% | $570M | — |
| CORT Corcept Therapeutics Incorporated | $86.31 | +0.52% | $9.33B | — |
| ABUS Arbutus Biopharma Corporation | $4.20 | -0.24% | $832M | — |
| RLYB Rallybio Corporation | $16.65 | +0.06% | $88.5M | — |
| ANAB AnaptysBio, Inc. | $48.77 | +0.08% | $1.46B | — |
| PHAR Pharming Group N.V. | $11.20 | +4.97% | $793M | — |
| ICCC ImmuCell Corporation | $10.30 | +0.49% | $93.6M | — |
| ACAD ACADIA Pharmaceuticals Inc. | $19.74 | +0.05% | $3.40B | — |
| ORMP Oramed Pharmaceuticals Inc. | $4.08 | -1.21% | $170M | — |
| PTGX Protagonist Therapeutics, Inc. | $140.32 | +1.37% | $9.08B | — |
| RPRX Royalty Pharma plc | $63.86 | +0.17% | $28.4B | — |
| ELVN Enliven Therapeutics, Inc. | $41.49 | -0.07% | $3.04B | — |
| NAGE Niagen Bioscience Inc | $2.40 | -1.08% | $190M | — |
| BLTE Belite Bio, Inc. | $143.35 | -2.70% | $5.77B | — |
| CLYM Climb Bio, Inc. | $8.81 | -13.54% | $506M | — |
| MBX MBX Biosciences | $48.50 | -3.88% | $2.34B | — |
| QTTB Q32 Bio Inc. | $8.45 | -2.31% | $252M | — |
| TGTX TG Therapeutics, Inc. | $54.79 | +1.14% | $8.39B | — |
| ALKS Alkermes plc | $44.44 | +1.86% | $7.46B | — |
| BMRN BioMarin Pharmaceutical Inc. | $55.95 | -1.20% | $10.8B | — |
| MANE Veradermics, Incorporated | $137.39 | -1.00% | $5.74B | — |
| ORIC ORIC Pharmaceuticals, Inc. | $8.96 | -32.00% | $928M | — |
Score IA par Stock Expert AI · Données de prix : FMP / Yahoo Finance